This inventor holds 2 USPTO granted patents. Top assignee: Tel Aviv University. Active years: 2011-2012.
Company Filing History:
Years Active: 2011-2012
Title: Irena Shur: Innovator in Cancer and Skeletal Disorder Treatments
Introduction
Irena Shur is a prominent inventor based in Tel Aviv, Israel. She has made significant contributions to the fields of biotechnology and medicine, particularly in the development of innovative treatments for cancer and skeletal disorders. With a focus on polypeptides and their applications, her work has garnered attention in the scientific community.
Latest Patents
Irena Shur holds 2 patents that highlight her groundbreaking research. Her latest patents include the development of polypeptides and polynucleotides encoding the same, along with antibodies that can be used for diagnosing and treating cancer and skeletal disorders. One of her notable inventions involves an isolated polypeptide that comprises an amino acid sequence at least 88% homologous to SEQ ID NO: 15 (human), as determined by BlastP using default parameters. This isolated polypeptide is capable of promoting cell adhesion and/or cell homing, which is crucial for effective treatment strategies.
Career Highlights
Irena Shur is affiliated with Tel Aviv University, where she conducts her research and contributes to the academic community. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.
Collaborations
Irena collaborates with Dafna Benayahu, who is also a notable figure in the field. Their partnership exemplifies the collaborative spirit of research and innovation in addressing complex medical challenges.
Conclusion
Irena Shur's contributions to the fields of biotechnology and medicine are significant, particularly in the development of treatments for cancer and skeletal disorders. Her innovative patents and collaborations reflect her dedication to advancing medical science and improving patient care.